期刊文献+

肥厚型梗阻性心肌病化学消融术中急性房室传导阻滞的预后价值 被引量:1

Prognostic value of acute heart block after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy
原文传递
导出
摘要 目的探讨肥厚型梗阻性心肌病(HOCM)行经皮经腔间隔心肌化学消融术(PTSMA)中急性房室传导阻滞对预后的影响。方法入选94例HOCM患者行PTSMA,术中及术后严密监测心电图变化,分析术中出现的各种心律失常对患者预后的影响。结果术中出现急性完全性房室传导阻滞的26例患者中,返回冠心病监护病房后有11例(42.3%)出现亚急性室内传导阻滞,2例(7.7%)出现亚急性一度房室传导阻滞,2例(7.7%)出现亚急性完全性房室传导阻滞,其余11例均为术中出现的一过性传导阻滞,术后均恢复正常传导。术中未出现急性完全性房室传导阻滞的68例患者中,术后14例(20.6%)出现亚急性室内传导阻滞,2例(2.9%)出现亚急性一度房室传导阻滞,1例(1.5%)出现亚急性完全性房室传导阻滞。在术中出现急性传导阻滞并继发亚急性传导阻滞的患者预后不良,传导阻滞持续时间平均42.00h,术中无急性传导阻滞而术后新发亚急性传导阻滞的患者,传导阻滞持续时间平均7.33h(P〈0.01)。结论PTSMA中出现急性传导阻滞的患者,术后容易继发亚急性传导阻滞,特别是室内传导阻滞,并且传导系统恢复时间较长;而术中未出现传导阻滞的患者,即使术后出现亚急性传导阻滞,传导系统恢复也较快。 Objective To investigate the prognostic value of acute heart block (AHB) after percutaneous transluminal septal myocardial ablation (PTSMA) in patients with hypertrophic obstructive cardiomyopathy (HOCM). Methods Ninety-four HOCM patients underwent PTSMA were included in this study. Twelve-lead electrocardiograms were obtained during and post PTSMA. Association between clinic events and incidence of post-PTSMA AHB was analyzed. Results AHB was induced in 26 patients by PTSMA and disappeared in 11 patients shortly post PTSMA, subacute intraventricular conduction disturbances was seen in 11 (42.3%), subacute I°AVB in 2(7.7%) and subacute Ⅲ°AVB in another 2 (7.7%) patients. Among 68 patients without AHB during PTSMA, intraventricular conduction disturbances was evidenced in 14 patients (20.6%), I° AVB in 2 (2.9%) and Ⅲ° AVB in 1 patient (1.5%) after PTSMA. AHB patients with subacute heart block were associated with poor prognosis (conduction block duration was 42. 00 h) while patients without AHB was associated with benign prognosis even with new onset of subacute heart block ( conduction block duration was 7.33 h, P 〈 0. 01). Conclusion Patients with AHB during PTSMA are at higher risk for subacute heart block, especially intraventricular conduction disturbances. AHB patients with subacute heart block were associated with poor prognosis and longer recovery time of conducting system.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2009年第2期149-151,共3页 Chinese Journal of Cardiology
关键词 心肌病 肥厚性 导管消融术 心脏传导阻滞 Cardiomyopathy,hypertrophic Catheter ablation Heart block
  • 相关文献

参考文献5

  • 1中华心血管病杂志编委会经皮经腔间隔心肌消融术治疗专题组.经皮经腔间隔心肌消融术治疗的参考意见[J].中华心血管病杂志,2001,29(7):434-435. 被引量:54
  • 2Harthorne JW, Baron SS. Atherosclerosis, the conduction system, and cardiac pacing//Fuster V, Ross R, Topol EJ. Atherosclerosis and coronary artey disease. Philadelphia, PA : Lippincott-Raven, 1996 : 1013-1030. 被引量:1
  • 3Chen AA, Palacios IF, Mela T, et al. Acute predictors of subacute complete heart block after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol,2006,97 : 254-269. 被引量:1
  • 4Gietzen FH, Leuner CJ, Rante-Kreinsen U, et al. Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J, 1999,20:1342-1354. 被引量:1
  • 5Reinhard W, Ten Cate FJ, Scholten M, et al. Permanent pacing for complete atrioventricular block after nonsurgical (alchol) septal reduction in patients with obstructive hypertrophic cardiomyopathy. Am J Cardiol,2004,93 : 1064-1066. 被引量:1

共引文献53

同被引文献21

  • 1Ivens E. Hypertrophic cardiomyopathy [J]. Heart Lung Cir- culation, 2004, Suppl 3 : S48-S55. 被引量:1
  • 2Leonardir A, Kransdorf EP, Simel DL, et al. Meta-analyses of septal reduction therapies for obstructive hypertrophic cardiomyopathy:comparative rates of overall mortality and sudden cardiac death after treatment [J]. Circ Cardiovasc In- terv,2010,3 (2) :97-104. 被引量:1
  • 3Agarwal S,Tuzeu EM,Desai MY,et al. Updated meta-anal- ysis of septal alcohol ablation versus myeetomy for hyper- trophic cardiomyopathy [J]. J Am Coil Cardiol,2010,55 (8) :823-834. 被引量:1
  • 4Jensen MK,Prinz C, Horstkotte D, et al. Alcohol septal ab- lation in patients with hypertrophic obstructive cardiomy- opathy:low incidence of sudden cardiac death and re- duced risk profile [J]. Heart,2013,99(14) : 1012-1017. 被引量:1
  • 5Veselka J, Lawrenz T, Stellbrink C,et al. Early outcomes of alcohol septal ablation for hypertrophic obstructive car- diomyopathy:a European muhieenter and multinational study [J]. Catheter Cardiovasc Interv,2014,84 (1) : 101-107. 被引量:1
  • 6Sigwart U. Non--surgical myocardial reduction for hyper- trophic obstructive cardiornyopathy [J]. Lancet, 1995,346 (8969) :211-214. 被引量:1
  • 7Van der Lee C, Scholzel B, ten Berg JM, et al. Usefulness of clinical,echocardiographic,and procedural characteris- tics to predict outcome after percutaneous transluminal septal myocardial ablation [J]. Am J Cardiol,2008,101(9) : 1315-1320. obstructive cardiomyopathy [J]. Clin Res Cardiol, 2007,96 (12) : 851-855. 被引量:1
  • 8Seggewiss H,Rigopoulos A,Welge D,et al. Long-term follow-up after percutaneous septal ablation in hyper- trophic. 被引量:1
  • 9Nemes A,Balazs E,Soliman OI,et al. Long-term prognos- tic value of coronary flow velocity reserve in patients with hypertrophic cardiomyopathy:9-year follow-up results from SZEGED study [J]. Heart Vessels,2009,24(5) : 552-356. 被引量:1
  • 10Malek LA,Chojnowska L,Klopotowski M,et al. Long term exercise capacity in patients with hypertrophic cardiomy- opathy treated with percutaneous transluminal septal my- ocardial ablation [J]. Eur J Heart Fail,2008,10(11) : 1123- 1126. 被引量:1

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部